• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Vanguard Scientific Announces Partnership with Rymedi

Share:

December 16, 2019

Vanguard Scientific Systems, Inc., a premier provider of equipment, systems and performance solutions servicing the botanical extraction industry, has announced a strategic partnership and exclusive industry licensing partnership with Rymedi, a global leader in block-chain enabled compliance, traceability and regulatory adherence technologies. Utilizing Rymedi’s expertise in global pharmaceutical regulatory compliance, the Company will be able to enhance their offerings to enable clients the capability to meet the domestic and international regulatory requirements of the cannabinoid industry.

The partnership will offer leading-edge expertise and solution-based services which include, GS1 global labeling standardization, international as well as domestic export readiness and product conformity, Quality Management System development as well as on demand document control and validation for clients looking to provide high-quality products of CGP and pharma-grade standards.

“As the Cannabinoid market continues to expand and regulations are being defined by state, country and region, understanding and navigating the evolving landscape of compliance can make the difference between generating revenue and producing a product which cannot be sold,” said CEO of Vanguard Scientific, Matthew Anderson. “For companies, especially ones navigating the U.S. hemp industry, having a team of quality experts and a technological solution providing an additional layer of compliance support will be the key to long-term consumer and patient success.”

“With our experience in highly regulated markets and Vanguard’s advanced processing systems, we’re perfectly positioned to deliver immutable compliance which is required to deliver trusted, high quality products – especially in geographies and industries where fraud and compliance concerns remain high,” said CEO of Rymedi, David Stefanich.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

The entire suite of Vanguard Quality Products and Solutions are now available to clients globally. By engaging with a Vanguard integration specialist, clients are able to receive an initial gap analysis and review of current operations in order to assure that their goals and desired product targets are being appropriately planned for, and the quality systems required are developed and implemented to meet the market.

Source: Prnews Wire

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Sesen Bio Stockholders Approve Merger with Carisma TherapeuticsSesen Bio Stockholders Approve Merger with Carisma Therapeutics
  • Same-Day Pharmacy Delivery NowRx Nabs $3M to Expand COVID-19 Pharmacy DeliverySame-Day Pharmacy Delivery NowRx Nabs $3M to Expand COVID-19 Pharmacy Delivery
  • Alvotech and Fuji Pharma Enter into Exclusive Partnership for Development and Commercialization of Biosimilars in JapanAlvotech and Fuji Pharma Enter into Exclusive Partnership for Development and Commercialization of Biosimilars in Japan
  • Recursion Announces Collaboration and $50 Million Investment from NVIDIA to Accelerate Groundbreaking Foundation Models in AI-Enabled Drug DiscoveryRecursion Announces Collaboration and $50 Million Investment from NVIDIA to Accelerate Groundbreaking Foundation Models in AI-Enabled Drug Discovery
  • Cascade Vision Center Merges with Sterling VisionCascade Vision Center Merges with Sterling Vision
  • Immersive Experiences Could Help Educate Patients, Cut Down on Video Call FatigueImmersive Experiences Could Help Educate Patients, Cut Down on Video Call Fatigue
  • Alaya.bio Acquires Key Assets From Ixaka France, Accelerating the Progress of Its Novel In Vivo CAR-T Immunotherapy PlatformAlaya.bio Acquires Key Assets From Ixaka France, Accelerating the Progress of Its Novel In Vivo CAR-T Immunotherapy Platform
  • Optimize.health Raises $15.6M for Remote Patient Monitoring PlatformOptimize.health Raises $15.6M for Remote Patient Monitoring Platform

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications